ArticleJournal of Indian Society of Periodontology
Treatment of periodontal infrabony defect using particulate dentin graft and recombinant human platelet-derived growth factor.
Article in Journal of Indian Society of Periodontology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bone Grafts: Everything You Need to Know.Journal of periodontal research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontal bone defects pose significant challenges in dentistry, necessitating effective treatment strategies. This case report explores the regenerative potential of using a combination of particulate dentin graft (PDG) derived from extracted teeth and recombinant human platelet-derived growth factor (rhPDGF) as bone graft material for the treatment of human periodontal infrabony defects. A 44-year-old male patient presented with a 9 mm pocket probing depth (PPD) and an 8 mm infrabony defect depth mesial to #13, with no gingival recession (GR). Following Phase I therapy, open flap debridement and grafting with PDG and rhPDGF were performed. Clinical and radiographic measurements were taken at baseline and 6 and 12 months. At 12 months, a 6 mm reduction in PPD and clinical attachment level gain were observed with no GR. 5 mm (83.33%) bone fill was seen radiographically. Within the limitations of this case report, the utilization of PDG with rhPDGF for the treatment of infrabony periodontal defects has emerged as a promising regenerative therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.